###begin article-title 0
Matrix Metalloproteinase-3 Genotypes Influence Recovery from Hepatitis B Virus Infection
###end article-title 0
###begin p 1
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 41 58 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 60 63 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 369 372 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
###xml 420 423 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 557 560 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 883 886 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 899 907 <span type="species:ncbi:9606">patients</span>
###xml 1121 1124 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The reasons for the viral persistence of hepatitis B virus (HBV) infection are unknown, but are probably related to host immune factors. Several matrix metalloproteinases (MMPs) can regulate an inflammatory response. The aim of this study was to assess the effects of the single nucleotide polymorphisms (SNPs) of MMP-3 and -9 genes on the susceptibility to persistent HBV infection. We studied 489 Korean patients with HBV infection (144 inactive carriers, 182 chronic hepatitis, and 163 liver cirrhosis) and 174 healthy individuals who had recovered from HBV infection. MMP-3 gene SNPs were identified at two polymorphic sites (codon 45 [E45K] and codon 96 [D96D]) and MMP-9 gene SNPs at three polymorphic sites (codon 279 [R279Q], codon 607 [G607G], and codon 668 [Q668R]) in study subjects. The frequency of T allele at third position of codon 96 in the MMP-3 gene was higher in HBV persistence patients when analyzed by co-dominant model (age- and sex-adjusted OR=1.242, 95% CI=1.001-1.540, p=0.049). In conclusion the T allele at the third position of codon 96 in the MMP-3 gene might be associated with persistent HBV infection.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
###xml 19 22 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 60 66 <span type="species:ncbi:9606">people</span>
###xml 244 247 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 384 387 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 569 572 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Hepatitis B virus (HBV) infection affects about 400 million people worldwide and is the most common cause of acute and chronic liver disease especially in several areas of Asia including Korea. Three factors thought to influence the outcome of HBV infection have been virus itself, host genetic factors, and environmental factors. Initially, the majority of host genetic studies with HBV infection have focused on human leukocyte antigen associations (1, 2). Recent studies showed that cytokine genetic polymorphisms have an association with the development of chronic HBV infection (3) and the progression of the infection (4).
###end p 3
###begin p 4
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
The matrix metalloproteinases (MMPs) are thought to play key roles in embryonic development, morphogenesis, reproduction, and tissue remodeling (5). Although the main function of MMPs is the removal of extracellular matrix (ECM) during tissue resorption, their roles in infectious disease are deemed to be considerable. The exact role of most MMPs in inflammatory conditions has not yet been elucidated, even to the extent of understanding whether they function to improve or worsen inflammation. Several MMPs were reported to regulate an inflammatory response by controlling the activity and mobilization of chemokines (6).
###end p 4
###begin p 5
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 480 481 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
MMP-3, an important member of metalloproteinase family, is produced by various types of cells; fibroblast, smooth muscle cells, and macrophages. MMP-3 is known to mediate the release of macrophage chemotactic activity from chondrocytes (7). MMP-9 is one of the important MMP family members in terms of inflammation. Activated neutrophils release MMP-9, which degrades and neutralizes the serine protease inhibitor alpha1-antiproteinase, a potent inhibitor of neutrophil elastase (8).
###end p 5
###begin p 6
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 158 161 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The aim of this study was to clarify whether MMP3 or MMP9 gene single nucleotide polymorphisms (SNPs) could predict the likelihood of viral persistence after HBV infection in a single ethnic Korean population.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Study subjects
###end title 8
###begin p 9
###xml 232 240 <span type="species:ncbi:9606">patients</span>
###xml 349 352 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
###xml 849 852 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 882 890 <span type="species:ncbi:9606">patients</span>
###xml 1066 1069 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1090 1098 <span type="species:ncbi:9606">patients</span>
###xml 1453 1456 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The case-control population included 663 Korean adults who were enrolled from the outpatient clinics of the Department of Gastroenterology, Ajou University Hospital (Suwon, Korea) between March 2002 and December 2003. Of these, 489 patients who had been positive for both HBsAg and anti-HBc IgG for more than 6 months were defined as the persistent HBV infection (M=364, F=125, aged 16-77 yr, mean +/-SD; 41.84+/-10.98). They were regularly followed up with blood tests for serum transaminase, HBeAg/anti-HBe and alpha-fetoprotein (AFP), and with ultrasonography or computed tomography of the liver at an interval of every 6 months for more than 12 months. Of the 489, 144 patients were considered to be inactive HBsAg carriers based on sustained normal alanine aminotransferase (ALT) levels and positivity for anti-HBe and an undetectable level of HBV DNA in serum. A total of 182 patients were found to have chronic hepatitis, manifested by elevated ALT (>/=2 twice the upper limit of normal) at least once during the follow-up period and positivity for HBeAg and HBV-DNA. A total of 163 patients were diagnosed as liver cirrhosis based on the typical morphologic findings on computed tomography/ultrasound and corresponding laboratory features or evidence of portal hypertension. None of them had hepatocellular carcinoma. In addition, we evaluated 174 healthy individuals (M=128, F=46, aged 26-75 yr, mean+/-SD; 48.73+/-9.13) who had recovered from HBV infection (HBsAg [-], anti-HBc IgG [+], anti-HBs [+]) and visited the Center for Health Promotion of Ajou University Hospital during the period of the study as a control group.
###end p 9
###begin p 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 167 178 <span type="species:ncbi:11103">hepatitis C</span>
###xml 388 393 <span type="species:ncbi:9606">Human</span>
Patients who were positive for anti-HBs and negative for anti-HBc IgG, and patients with other types of chronic liver disease such as alcoholic liver disease, chronic hepatitis C, steatohepatitis, and Wilson's disease were excluded from the study. All the subjects were Korean, a single ethnic group. Informed consent was obtained from each subject, and the Institutional Review Board of Human Research of Ajou University Hospital approved the study protocol.
###end p 10
###begin title 11
Genotyping
###end title 11
###begin p 12
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 176 179 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We screened 40 Koreans to identify polymorphisms in the MMP3 and MMP9 genes. Among the identified polymorphisms, five were selected for larger scale genotyping (n=663) for the HBV association study based on frequencies and/or location. We assessed SNPs at two polymorphic sites in the MMP3 gene the (first position of codon 45 [E45K, G to A, rs679620] and the third position of codon 96 [D96D, C to T, rs602128]) and at three polymorphic sites in the MMP9 gene (the second position of codon 279 [R279Q, G to A, rs17576], third poison of codon 607 [G607G, G to A, rs13969], and the second position of codon 668 [Q668R, A to G, rs2274756]) in study subjects.
###end p 12
###begin p 13
###xml 311 318 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 703 713 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8482;</sup>
###xml 757 758 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1225 1235 1212 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8482;</sup>
###xml 1331 1341 1309 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8482;</sup>
###xml 1827 1837 1796 1797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8482;</sup>
Genomic DNA was extracted from 300 microL whole blood using a DNA Purification kit (GENTRA, Minneapolis, MN, U.S.A.), according to the manufacturer's instructions. The SNPs were detected by polymerase chain reaction (PCR) amplification. The sequence of the primers and probes used in the assays are provided in Table 1. The parameters for thermocycling were as follows: an initial activation step of 95℃ for 10 min preceded the cycling program, followed by 35 cycles of denaturation for 95℃, annealing at 72℃ for 1 min, and final extension at 72℃ for 7 min. Each PCR product was purified by a Qiagen PCR purification kit, and the polymorphisms were detected by single base primer extension assay (SNP ITtrade mark) using the method as previously described (9). Briefly, the genomic DNA region spanning the polymorphic site was PCR-amplified using one phosphorothiolated primer and one regular PCR primer. The amplified PCR products were digested with exonuclease. The 5'-phosphorothioates protect one strand of the PCR product from exonuclease digestion, resulting in the generation of a single-stranded PCR template. The single-stranded PCR template is overlaid onto a 384-well plate that contains covalently attached SNP-ITtrade mark extension primer designed to hybridize immediately adjacent to the polymorphic site. The SNP-ITtrade mark primer is extended for a single base with DNA polymerase and mixture of appropriate acycloterminator that is labeled with either FITC or biotin and complementary to the polymorphic nucleotide. The identity of the incorporated nucleotide is determined with serial colorimetric reactions with anti-FITC-AP and streptavidin-HRP, respectively. The results of yellow and/or blue color developments were analyzed with an ELISA reader, and the final genotype calls were made with the QCReviewtrade mark program.
###end p 13
###begin p 14
All genotyping results were quality controlled by including duplicate samples. We included 6 replicate samples for each of 96 well plates and checked concordances. We accepted data from a plate only if they have less than one mismatches per each plate. Overall concordances were over 99.9% throughout the experiments.
###end p 14
###begin title 15
Statistical analysis
###end title 15
###begin p 16
###xml 32 33 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 598 599 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 630 631 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 327 330 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 349 352 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
For univariate analysis, the chi2 test was used for Hardy-Weinberg equilibrium of alleles at individual loci and independent sample t-test for normally distributed continuous variables. For multivariate analysis, multiple logistic regression analysis was performed to determine which factor (s) was the most discriminating for HBV persistence after HBV infection, where age, sex, cytokine, and its related gene polymorphisms were independent variables. Odds ratios (ORs) with 95% confidence intervals were computed by logistic regression using SPSS version 11.0 software (Chicago, IL, U.S.A.). All p values were two-tailed, and a p value <0.05 was considered to indicate statistical significance throughout the study.
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 441 442 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 136 139 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The clinical and demographic characteristics of the case-control populations were compared. There was no significant difference between HBV persistence and clearance subjects in terms of sex (M:F=364:125 vs. 128:46, respectively). Although an effort was made to obtain an age-matched cases and controls, the age was younger in the persistence group than that in the clearance group (41.84+/-10.98 vs. 48.73 +/-9.13, mean+/-SD, respectively, p=0.00).
###end p 18
###begin p 19
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 236 246 236 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wild (W)/W</italic>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W/V</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V/V</italic>
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W/W</italic>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W/V</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V/V</italic>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W/W</italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W/V</italic>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V/V</italic>
###xml 78 81 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 98 101 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Table 2 shows the summarized data regarding the genotype distributions in the HBV persistence and HBV clearance groups. In an analyzing model in which a co-dominant (additive) effect of the variant (V) allele was assumed, the genotypes Wild (W)/W, W/V and V/V were coded as 0, 1, and 2, respectively. When a dominant effect was assumed, genotype W/W was coded as 0, and W/V and V/V combined were coded as 1. Accordingly, scores of 0 for W/W and W/V combined and of 1 for V/V were used in a model that assumed a recessive effect.
###end p 19
###begin p 20
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 86 89 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 106 109 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 263 266 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Genotype frequencies in the MMP3 and MMP9 exon regions were analyzed in patients with HBV persistence and HBV clearance subjects. Among the five SNP sites analyzed, T allele carriers at the third position of codon 96 in the MMP3 gene had a weak correl ation with HBV persistence in a codominant model (age- and sex-adjusted ORs; 1.242, p=0.049).
###end p 20
###begin p 21
###xml 212 215 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
On the basis of unconditional logistic regression analysis with adjustment for age and sex, no statistically significant association was observed with other SNP sites in terms of the susceptibility to persistent HBV infection.
###end p 21
###begin title 22
DISCUSSION
###end title 22
###begin p 23
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP9</italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 149 152 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 171 174 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 270 273 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 454 457 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We examined the polymorphisms in exon regions of MMP3 and MMP9 genes in 663 Korean subjects and analyzed the association of these polymorphisms with HBV persistence after HBV infection. The T allele at the third position of codon 96 in the MMP3 gene was associated with HBV persistence in a co-dominant model (p=0.049). This is the first study to demonstrate that genetically determined differences in the MMP3 gene may be a determinant of recovery from HBV infection.
###end p 23
###begin p 24
###xml 335 337 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 531 533 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 625 627 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 15 18 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 284 287 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 414 417 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 514 517 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 610 613 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Recovery after HBV infection is known to be dependent on the integrated activities of the patients' immune systems and the cytokine network. Recent studies have shown that several immunoregulatory cytokines such as interferon-gamma and tumor necrosis factor-alpha (TNF-alpha) inhibit HBV replication through the non-cytolytic process (10). We previously reported that the association between various cytokines and HBV persistence. We showed specific interleukin-10 and TNF-alpha promoter SNPs were associated with HBV persistence (11), but there was no association between mannose binding lectin gene SNPs and HBV infection (12).
###end p 24
###begin p 25
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 615 617 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 869 871 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
MMPs represent a family of at least 20 zinc-dependent proteolytic enzymes that are important in physiological and disease-related ECM remodeling (5). As our knowledge of this family continues to grow, we are learning that their activities are not limited to matrix degradation (6). MMPs directly modulate chemokine activity. Processing by MMP-9 leads to a loss of chemotactic activity of various chemokines, such as CXCL5, CXCL6, and mouse CXCL5 (13). By contrast, the processing of CXCL8 by MMP-9 markedly increases its chemotactic activity (14). MMP-2, -3, and -9 can cleave and activate the IL-1beta, precursor (15). Furthermore, after activating IL-1beta, MMP-3 degrades the biologically active cytokine, which can also be inactivated in vitro by MMP-1, -2, and -9. These data indicate a dual role for MMPs in biphasic modulation of inflammatory mediator activity (16).
###end p 25
###begin p 26
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 259 262 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
Currently available data suggest that MMPs may have important roles in liver fibrosis and cirrhosis development, but a comprehensive description of MMP regulation in chronic hepatitis B is still lacking. Recent investigation suggested that the replication of HBV might cause increased secretion of MMP-2 that might, in turn, enhance the inflammation of liver tissue and lead to chronic hepatitis, since an elevated activity of MMP-2 has been related to inflammation in several systems (17). Previous reports showed that plasma activities of MMP-9 were elevated in hepatocelluar carcinoma patients (18). Although a few investigators discussed the role of MMPs in liver disease, most of them had focused on their participation in cancer development and metastasis, some on liver cirrhosis, and few on chronic hepatitis.
###end p 26
###begin p 27
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 180 183 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 223 226 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 389 406 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 508 511 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 564 567 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 670 673 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Although the correlation was not strong, the results of this study suggest that the genotype of codon 96 in the MMP3 gene might be a host genetic factor affecting immunity against HBV infection. MMP-3 has no proven role in HBV pathogenesis. MMPs play a role in modulating chemokine activity, and Ahn et al. reported that genetic variations in CCR5 and its lignad, RANTES with clearance of hepatitis B virus in a Korean population (19). Thus, these data suggest either a novel mechanism of immune response to HBV involving MMP-3 or an alternative role for MMP-3 in HBV pathogenesis. Further work is needed to determine the precise contribution of MMP-3 to the control of HBV infection.
###end p 27
###begin p 28
###xml 208 211 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 364 367 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
It would have been helpful to be able to correlate the precise levels of MMP-3 in our subjects. However, the MMP levels in sera would not be expected to be the representative of serum levels at the time when HBV persistence or recovery from infection was determined. A meaningful measurement of serum MMP levels in our cohort would require a sample taken prior to HBV infection, which was not available.
###end p 28
###begin p 29
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3</italic>
###xml 135 138 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 246 249 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
In conclusion, the carriers of T allele at the third position of codon 96 in the MMP3 gene have higher risk of viral persistence after HBV infection. The information about SNPs in MMP genes might be useful for host genetic studies, especially in HBV infection.
###end p 29
###begin article-title 30
###xml 20 37 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between hepatitis B virus infection and HLA-DR type in Korea
###end article-title 30
###begin article-title 31
###xml 60 77 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
###end article-title 31
###begin article-title 32
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 54 71 <span type="species:ncbi:10407">hepatitis B virus</span>
Cytokine gene polymorphisms in patients infected with hepatitis B virus
###end article-title 32
###begin article-title 33
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 117 134 <span type="species:ncbi:10407">hepatitis B virus</span>
Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus
###end article-title 33
###begin article-title 34
Matrix metalloproteinases
###end article-title 34
###begin article-title 35
Matrix metalloproteinases as modulators of inflammation and innate immunity
###end article-title 35
###begin article-title 36
Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption
###end article-title 36
###begin article-title 37
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
###end article-title 37
###begin article-title 38
From gels to chips: "minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms
###end article-title 38
###begin article-title 39
###xml 32 49 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 97 112 <span type="species:ncbi:10090">transgenic mice</span>
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
###end article-title 39
###begin article-title 40
###xml 28 45 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms
###end article-title 40
###begin article-title 41
###xml 28 45 <span type="species:ncbi:10407">hepatitis B virus</span>
Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population
###end article-title 41
###begin article-title 42
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1
###end article-title 42
###begin article-title 43
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities
###end article-title 43
###begin article-title 44
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing
###end article-title 44
###begin article-title 45
Degradation of interleukin 1beta by matrix metalloproteinases
###end article-title 45
###begin article-title 46
###xml 89 92 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 98 101 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers
###end article-title 46
###begin article-title 47
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma
###end article-title 47
###begin article-title 48
###xml 83 100 <span type="species:ncbi:10407">hepatitis B virus</span>
Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea
###end article-title 48
###begin p 49
###xml 45 72 45 72 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korean Health R &amp; D project</funding-source>
###xml 125 132 125 132 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A010383</award-id>
This study was supported by a grant from the Korean Health R & D project, Ministry of Health and Welfare, Republic of Korea (A010383).
###end p 49
###begin p 50
Sequences of PCR-amplifying primers and extension primers used in the SNP-IT assays
###end p 50
###begin p 51
SNP, single nucleotide polymorphism; PCR, polymerase chain reaction; MMP, matrix metalloproteinases.
###end p 51
###begin p 52
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP3/MMP9</italic>
###xml 53 56 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Association between MMP3/MMP9 gene polymorphisms and HBV persistence whilst controlling age and sex
###end p 52
###begin p 53
###xml 32 35 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 37 54 <span type="species:ncbi:10407">hepatitis B virus</span>
MMP, matrix metalloproteinases; HBV, hepatitis B virus; OR, odds ratio; CI, confidence interval.
###end p 53

